VEGFA and age-related macular degeneration: In a study of exudative AMD patients receiving intravitreal anti-VEGFs injections, it was shown that ranibizumab has a minimal effect on plasma-free VEGF concentrations, whereas Bevacizumab and Aflibercept caused a significant reduction of the free VEGF due to greater systemic exposure [34].